Angiotensin converting enzyme (ACE) and HydroxyMethylGlutaryl-CoA (HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium.
Journal Title: Pharmacological Reports - Year 2005, Vol 57, Issue
Abstract
Healthy endothelium is essential for undisturbed functioning of the cardiovascular system, while endothelial dysfunction leads to its various pathologies. For example endothelial dysfunction precedes clinical symptoms of atherothrombosis, such as acute coronary syndrome, ischemic stroke, peripheralarterial disease or diabetic microangiopathies e.g. retinopathy and nephropathy. Accordingly, pharmacological reversal of endothelial dysfunction may represent a new approach in preventing the aforementioned vasculopathies. In modern cardiovascular pharmacology, inhibitors of angiotensin converting enzyme (ACE-I) or inhibitors of HydroxyMethylGlutaryl-CoA (HMG-CoA) reductase (statins) are among the most widely used cardiovascular drugs. Originally, ACE-I and statins were introduced to clinical medicine to lower arterial blood pressureor to lower blood LDL cholesterol levels, respectively. They were respectively targeted to inhibit ACEin blood or to inhibit HMG-CoA reductase in the liver. Surprisingly, these two classes of drugs apart from their classic mechanisms of action exert pleiotropic endothelial actions, which involve the inhibition of ACE or HMG-CoA reductase within the endothelium, as well as other less understood endothelial mechanisms. Typically, therapeutic effectiveness of ACE-I by far exceeds the benefits expected from their hypotensive effect or as the matter of fact of other hypotensive drugs. Similarly, statins offer cardiovascular protection irrespective of initial LDL cholesterol levels in patients. In our view, it is the endothelial action of ACE-I or statins that contributes significantly to their anti-inflammatory, anti-thrombotic, and vasculoprotective actions. Importantly, actions of ACE-I or statins are not limited to the correction of functioning of a single endothelial mediator, but they do possess a broader spectrum of endotheliotropic properties that proved efficient in preventing atherothrombosis and other vasculopathies. Quite surprisingly, th ehistory of ACE-I and statins has a major impact for the future development in pharmacology of endothelium.
Authors and Affiliations
Stefan Chłopicki, Ryszard Gryglewski
Effect of selected antidepressant drugs on cytochrome P450 2B (CYP2B) in rat liver. An in vitro and in vivo study.
The aim of the present study was to investigate the influence of antidepressants with different chemical structures and mechanisms of action affecting serotonergic and/or noradrenergic systems - tricyclic antidepressant...
Taurine modulates calcium influx under normal and ototoxic conditions in isolated cochlear spiral ganglion neurons.
The effect of taurine on calcium homeostasis of isolated cochlear spiral ganglion neurons under normal and ototoxic conditions was investigated using fluo-3 calcium imaging. Sole application of taurine (15 mM) induced an...
Antidepressant-like effect of combined treatment with selective sigma receptor agonists and a 5-HT(1A) receptor agonist in the forced swimming test in rats.
The interaction between the selective sigma (sigma) receptor agonists and 8-OH-DPAT, a serotonin (5-HT)(1A) receptor agonist, was examined in the forced swimming test in rats. The results indicate that joint administrati...
Antinociception by metoclopramide, ketamine and their combinations in mice.
Background: Metoclopramide is a centrally acting antiemetic and ketamine is a general anesthetic used with sedatives, tranquilizers and analgesics. Metoclopramide has analgesic effects and its combination with ketamine c...
Effects of standard treatment on the dynamics of matrix metalloproteinases gene expression in patients with acute coronary syndromes.
Inflammation plays a critical role in the pathology of acute coronary syndrome (ACS). Matrix metalloproteinases (MMP) - proteolytic enzymes participating in plaque destabilization - are the crucial effectors of proinflam...